Chabiotech Co.,Ltd. (KOSDAQ:085660)

Chabiotech Statistics

Total Valuation

Chabiotech has a market cap or net worth of KRW 868.18 billion. The enterprise value is 1.73 trillion.

Market Cap	868.18B
Enterprise Value	1.73T

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Chabiotech has 75.96 million shares outstanding. The number of shares has increased by 1.49% in one year.

Current Share Class	75.96M
Shares Outstanding	75.96M
Shares Change (YoY)	+1.49%
Shares Change (QoQ)	+7.02%
Owned by Insiders (%)	13.75%
Owned by Institutions (%)	10.10%
Float	56.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.75
PB Ratio	1.09
P/TBV Ratio	5.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-22.64
EV / Sales	1.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.34

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 1.02.

Current Ratio	0.74
Quick Ratio	0.65
Debt / Equity	1.02
Debt / EBITDA	n/a
Debt / FCF	-4.40
Interest Coverage	-1.76

Financial Efficiency

Return on equity (ROE) is -14.75% and return on invested capital (ROIC) is -3.89%.

Return on Equity (ROE)	-14.75%
Return on Assets (ROA)	-2.64%
Return on Invested Capital (ROIC)	-3.89%
Return on Capital Employed (ROCE)	-7.27%
Revenue Per Employee	4.14B
Profits Per Employee	-274.29M
Employee Count	278
Asset Turnover	0.55
Inventory Turnover	19.97

Taxes

In the past 12 months, Chabiotech has paid 7.96 billion in taxes.

Income Tax	7.96B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.44% in the last 52 weeks. The beta is 0.42, so Chabiotech's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	-29.44%
50-Day Moving Average	11,179.80
200-Day Moving Average	11,453.57
Relative Strength Index (RSI)	60.47
Average Volume (20 Days)	192,994

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Chabiotech had revenue of KRW 1.15 trillion and -76.25 billion in losses. Loss per share was -1,338.52.

Revenue	1.15T
Gross Profit	303.70B
Operating Income	-87.80B
Pretax Income	-103.10B
Net Income	-76.25B
EBITDA	-33.89B
EBIT	-87.80B
Loss Per Share	-1,338.52

Balance Sheet

The company has 390.41 billion in cash and 812.32 billion in debt, giving a net cash position of -421.91 billion or -5,554.65 per share.

Cash & Cash Equivalents	390.41B
Total Debt	812.32B
Net Cash	-421.91B
Net Cash Per Share	-5,554.65
Equity (Book Value)	799.94B
Book Value Per Share	4,784.68
Working Capital	-274.76B

Cash Flow

In the last 12 months, operating cash flow was -104.92 billion and capital expenditures -79.89 billion, giving a free cash flow of -184.81 billion.

Operating Cash Flow	-104.92B
Capital Expenditures	-79.89B
Free Cash Flow	-184.81B
FCF Per Share	-2,433.08

Margins

Gross margin is 26.38%, with operating and profit margins of -7.63% and -6.56%.

Gross Margin	26.38%
Operating Margin	-7.63%
Pretax Margin	-8.96%
Profit Margin	-6.56%
EBITDA Margin	-2.94%
EBIT Margin	-7.63%
FCF Margin	n/a

Dividends & Yields

Chabiotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.49%
Shareholder Yield	n/a
Earnings Yield	-8.78%
FCF Yield	-21.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 2, 2014. It was a reverse split with a ratio of 0.7262.

Last Split Date	Jun 2, 2014
Split Type	Reverse
Split Ratio	0.7262

Scores

Chabiotech has an Altman Z-Score of 0.67 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.67
Piotroski F-Score	3